P Cuijpers1, E H Turner2, D C Mohr3, S G Hofmann4, G Andersson5, M Berking6, J Coyne7. 1. Department of Clinical Psychology, VU University Amsterdam, The Netherlands. 2. Behavioral Health and Neurosciences Division, Portland Veterans Affairs Medical Center, Portland, OR, USA. 3. Department of Preventive Medicine, Northwestern University, Chicago, IL, USA. 4. Department of Psychology, Boston University, Boston, MA, USA. 5. Department of Behavioral Sciences and Learning, Swedish Institute for Disability Research, Linköping University, Sweden. 6. Department of Clinical Psychology, Philipps-University of Marburg, Germany. 7. Health Psychology Section, Department of Health Sciences, University Medical Center, Groningen, University of Groningen, The Netherlands.
Abstract
BACKGROUND: The effects of antidepressants for treating depressive disorders have been overestimated because of selective publication of positive trials. Reanalyses that include unpublished trials have yielded reduced effect sizes. This in turn has led to claims that antidepressants have clinically insignificant advantages over placebo and that psychotherapy is therefore a better alternative. To test this, we conducted a meta-analysis of studies comparing psychotherapy with pill placebo. METHOD: Ten 10 studies comparing psychotherapies with pill placebo were identified. In total, 1240 patients were included in these studies. For each study, Hedges' g was calculated. Characteristics of the studies were extracted for subgroup and meta-regression analyses. RESULTS: The effect of psychotherapy compared to pill placebo at post-test was g = 0.25 [95% confidence interval (CI) 0.14-0.36, I² = 0%, 95% CI 0-58]. This effect size corresponds to a number needed to treat (NNT) of 7.14 (95% CI 5.00-12.82). The psychotherapy conditions scored 2.66 points lower on the Hamilton Depression Rating Scale (HAMD) than the placebo conditions, and 3.20 points lower on the Beck Depression Inventory (BDI). Some indications for publication bias were found (two missing studies). We found no significant differences between subgroups of the studies and in meta-regression analyses we found no significant association between baseline severity and effect size. CONCLUSIONS: Although there are differences between the role of placebo in psychotherapy and pharmacotherapy research, psychotherapy has an effect size that is comparable to that of antidepressant medications. Whether these effects should be deemed clinically relevant remains open to debate.
BACKGROUND: The effects of antidepressants for treating depressive disorders have been overestimated because of selective publication of positive trials. Reanalyses that include unpublished trials have yielded reduced effect sizes. This in turn has led to claims that antidepressants have clinically insignificant advantages over placebo and that psychotherapy is therefore a better alternative. To test this, we conducted a meta-analysis of studies comparing psychotherapy with pill placebo. METHOD: Ten 10 studies comparing psychotherapies with pill placebo were identified. In total, 1240 patients were included in these studies. For each study, Hedges' g was calculated. Characteristics of the studies were extracted for subgroup and meta-regression analyses. RESULTS: The effect of psychotherapy compared to pill placebo at post-test was g = 0.25 [95% confidence interval (CI) 0.14-0.36, I² = 0%, 95% CI 0-58]. This effect size corresponds to a number needed to treat (NNT) of 7.14 (95% CI 5.00-12.82). The psychotherapy conditions scored 2.66 points lower on the Hamilton Depression Rating Scale (HAMD) than the placebo conditions, and 3.20 points lower on the Beck Depression Inventory (BDI). Some indications for publication bias were found (two missing studies). We found no significant differences between subgroups of the studies and in meta-regression analyses we found no significant association between baseline severity and effect size. CONCLUSIONS: Although there are differences between the role of placebo in psychotherapy and pharmacotherapy research, psychotherapy has an effect size that is comparable to that of antidepressant medications. Whether these effects should be deemed clinically relevant remains open to debate.
Authors: Lata K McGinn; Anna Van Meter; Ian Kronish; Jessica Gashin; Karen Burns; Natalie Kil; Thomas G McGinn Journal: Cognit Ther Res Date: 2019-02-12
Authors: Toshi A Furukawa; Erica S Weitz; Shiro Tanaka; Steven D Hollon; Stefan G Hofmann; Gerhard Andersson; Jos Twisk; Robert J DeRubeis; Sona Dimidjian; Ulrich Hegerl; Roland Mergl; Robin B Jarrett; Jeffrey R Vittengl; Norio Watanabe; Pim Cuijpers Journal: Br J Psychiatry Date: 2017-01-19 Impact factor: 9.319
Authors: Jeffrey R Vittengl; Robin B Jarrett; Erica Weitz; Steven D Hollon; Jos Twisk; Ioana Cristea; Daniel David; Robert J DeRubeis; Sona Dimidjian; Boadie W Dunlop; Mahbobeh Faramarzi; Ulrich Hegerl; Sidney H Kennedy; Farzan Kheirkhah; Roland Mergl; Jeanne Miranda; David C Mohr; A John Rush; Zindel V Segal; Juned Siddique; Anne D Simons; Pim Cuijpers Journal: Am J Psychiatry Date: 2016-02-12 Impact factor: 18.112
Authors: Marie A Bakitas; Tor D Tosteson; Zhigang Li; Kathleen D Lyons; Jay G Hull; Zhongze Li; J Nicholas Dionne-Odom; Jennifer Frost; Konstantin H Dragnev; Mark T Hegel; Andres Azuero; Tim A Ahles Journal: J Clin Oncol Date: 2015-03-23 Impact factor: 44.544
Authors: John P A Ioannidis; Marcus R Munafò; Paolo Fusar-Poli; Brian A Nosek; Sean P David Journal: Trends Cogn Sci Date: 2014-03-18 Impact factor: 20.229